Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beihai Gofar Chuanshan Biological Co Buyback Yield % Chart
SHSE:600538 vs CTVA, CF, MOS: Buyback Yield % Comparison
For the Agricultural Inputs subindustry, Beihai Gofar Chuanshan Biological Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beihai Gofar Chuanshan Biological Co Buyback Yield % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Beihai Gofar Chuanshan Biological Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Beihai Gofar Chuanshan Biological Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beihai Gofar Chuanshan Biological Co (SHSE:600538) has a Buyback Yield % of 0.00 as of Jul. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. According to the industry distribution chart, Beihai Gofar Chuanshan Biological Co ranks #999999 out of 50 companies in the Agriculture industry.
Is Beihai Gofar Chuanshan Biological Co's Buyback Yield % too high?
Beihai Gofar Chuanshan Biological Co's current Buyback Yield % is 0.00. Based on the distribution chart, Beihai Gofar Chuanshan Biological Co ranks #999999 out of 50 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Beihai Gofar Chuanshan Biological Co has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beihai Gofar Chuanshan Biological Co's Buyback Yield % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Beihai Gofar Chuanshan Biological Co ranks #999999 out of 50 companies for Buyback Yield %. This places Beihai Gofar Chuanshan Biological Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for an Agriculture company?
A good Buyback Yield % depends on the Agriculture industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. Beihai Gofar Chuanshan Biological Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beihai Gofar Chuanshan Biological Co stock overvalued right now?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co (SHSE:600538) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.10, compared to a current price of ¥4.68 — trading 14.1% above its estimated fair value. The current Buyback Yield % is 0.00. Beihai Gofar Chuanshan Biological Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Beihai Gofar Chuanshan Biological Co (SHSE:600538), the current Buyback Yield % is 0.00 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beihai Gofar Chuanshan Biological Co (SHSE:600538) Overvalued in 2026?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co stock appears to be overvalued.
The current stock price of ¥4.68 is trading 14.1% above its estimated GF Value™ of ¥4.10.
GuruFocus considers Beihai Gofar Chuanshan Biological Co to be Modestly Overvalued.
Key valuation signals for SHSE:600538:
Buyback Yield %: 0.00
GF Value™: ¥4.10 vs. price of ¥4.68 (14.1% above fair value)
No single metric tells the full story. See the SHSE:600538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beihai Gofar Chuanshan Biological Co Business Description
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
53GF Score
Get the complete analysis for SHSE:600538
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600538 has been successfully added to your 
